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Divergent Pharmacological Properties of SCN1A Splice Variants
Christopher H. Thompson, Kristopher M. Kahlig, Alfred L. George Jr.
Vanderbilt University, Nashville, TN, USA.
Voltage-gated sodium channels undergo alternative mRNA splicing. In the
human neuronal Nav1.1 channel encoded by SCN1A, a common genetic vari-
ant affecting an intron splice donor site alters the proportion of transcripts that
incorporate the canonical exon 5 (exon 5A) or an alternative (exon 5N) encod-
ing portions of the S3 and S4 segments of domain 1. Epileptic subjects with this
genetic variant require lower doses of anticonvulsant drugs such as phenytoin
compared with individuals lacking this variant. Because this genetic variant is
associated with a larger proportion of exon 5N containing transcripts in brain,
we hypothesized that differences in function and pharmacology of Nav1.1
channels containing either exon 5N or 5A account for the observed divergence
in anticonvulsant dose requirements. To examine differences in drug efficacy of
SCN1Asplice variants,we performedwhole-cell recording on tsA201 cells tran-
siently co-transfected with either Nav1.1-5A or Nav1.1-5N and two accessory
subunits (b1,b2). We examined voltage-dependence of activation, steady-state
inactivation, and recovery from fast inactivation and observed no significant
differences between splice variants. We also measured both steady-state block
and use-dependent block (10Hz) by phenytoin, carbamazepine, and lamotrigine.
Nav1.1-5N channels exhibited greater steady-state block by phenytoin(100mM)
(1655% vs. 256%) and lamotrigine(200mM) (2554% vs. 1452%) compared
to Nav1.1-5A. Additionally, Nav1.1-5N exhibited greater use-dependent block
by phenytoin (3955% vs. 2454%) and lamotrigine (2956% vs. 1852%).We
tested cells stably transfected with either Nav1.1-5A or Nav1.1-5N and both
b subunits using an automated planar patch clamp system (Patchliner, Nanion
Inc.) to perform concentration-response curves to determine steady-state and
inactivated state affinities for lamotrigine. Similar to conventional patch clamp
experiments, lamotrigine exhibited greater steady-state and inactivated state
affinity for Nav1.1-5N than Nav1.1-5A. These results suggest SCN1A tran-
scripts containing the alternative exon 5N encode channels that are more sensi-
tive to multiple anticonvulsant drugs.
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BisphenolAhas reached public attentiondue to its presence in foodandbeverages
following leaching fromplastic containers.. It is amonomer that is polymerized to
manufacture polycarbonate plastic food wrappings and it is detectable in the
blood of human populations in developed countries (Palanza et al. 2008, Environ-
mental Research). In animal studies and in vitro bisphenol A was shown to have
estrogenic effects. Data link bisphenol A exposure to a variety of diseases
including miscarriage, menstrual pain and cardiovascular syndromes.
The human heart voltage-gated sodium channel hNav1.5 was expressed in
HEK293t cells to determine the effect of bisphenol A on sodium channel
function.
With whole-cell patch clamp analysis, we show that bisphenol A reduces the
peak sodium current through hNav1.5 from a holding potential of 120 mV
with an EC50 of 54 5 8 mM This concentration is considerably higher than
has been found in beverages from plastic bottles. However, compared to other
known sodium channel blockers, such as lamotrigine or lidocaine, its efficacy is
approximately ten-fold higher.
Bisphenol A shifts steady-state fast inactivation to more hyperpolarized poten-
tials, whereas voltage-dependence of activation is unaffected. As with local
anesthetics, bisphenol A binds preferentially to the inactivated state. The asso-
ciation time constant, as determined by a single exponential fit of peak current
decline induced by 30 mM bisphenol A is approximately 14 times faster than
that induced by 300 mM lidocaine.
In conclusion, we have determined that bisphenol A has blocking effects on
hNav1.5 sodium currents that are more pronounced than those of known
blockers, such as lidocaine or lamotrigine.
Funding: AOR and BAW: BBSRC. AL: Robert-Bosch-Foundation.
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GlaxoSmithKline, Verona, Italy.Some clinically used drugs interact via state-dependent inhibition of voltage-
gated sodium channels. For example, cocaine, procaine or lidocaine preferen-
tially interact with, and stabilize the inactivated conformation of the channel.
Upon repetitive high frequency activation they cause a progressive inhibition
during the pulse train which is termed use-dependent inhibition.
Here we describe compounds that show the opposite behaviour, ie the inhibi-
tion is diminished during the pulse train.
To adequately determine the state-dependent interactions of drugs with sodium
channels, we developed a high-throughput electrophysiological assay using the
IonWorks(r) Quattro(tm) PPC platform. Compounds were tested against the
brain Nav1.3 sodium channel expressed in CHO cells. A train of 10 depolariz-
ing voltage steps from90mV to 0mV for 20ms (10Hz frequency) was applied
before and after compound addition. To evaluate the tonic block, inhibition of
the peak current at the first pulse was measured while the use-dependent block
was determined as the inhibition at the 10th pulse. Lidocaine shows the ex-
pected use-dependent inhibition. Surprisingly, we found compounds with the
opposite profile: the compound with the most pronounced effect blocked the
1st and 10th pulses by 72.356.1 % and 42.956.9 % (mean5SD, n¼5) at
10uM. In a second instance these compounds were tested against the cardiac
Nav1.5 and the peripheral nervous and neuroendocrine systems Nav1.7 observ-
ing similar effects. An in-depth comparison between use-dependent and reverse
use-dependent blockers was performed for parameters such as voltage-depen-
dent activation and inactivation, recovery from inactivation, and frequency
dependency. These data provide biophysical insights in the mechanism of
reverse use-dependent inhibition for Nav channels.
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OBJECTIVES. It was previously shown that eugenol, a phenylpropene, blocks
fast and reversibly voltage-gated Naþ channels (NaV), but little concern was
given to the blocker binding to different conformational states of channel mol-
ecule. Here we reported a detailed analysis of state-dependent effects of euge-
nol on tetrodotoxin-resistant (TTX-R) NaV isoforms, comparing them to those
of lidocaine, a reference blocker.
METHODS. TTX-R Naþ currents were recorded in dorsal root ganglia neu-
rons from newborn Wistar rats with whole-cell configuration of patch clamp
technique. Tetrodotoxin-sensitive Naþ currents were blocked by TTX 100nM
in the extracellular solution.
RESULTS and CONCLUSIONS. A dose-dependent fast blockade due to eu-
genol was observed in 0.2Hz time series depolarizations from a holding po-
tential of 110 mV to a 0 mV pulse. This tonic blockage is due to eugenol
binding to the closed state. The IC50 was 2.2850.10mM for eugenol com-
pared to 0.4450.08mM for lidocaine. The tonic NaV blockade was more ef-
fective when the membrane was held at more depolarized, still sublimiar,
holding potentials. This observation indicates a higher affinity of eugenol
for closed substates dwelled at less hyperpolarized potentials. No consistent
evidences for additional binding to open state were observed. A displacement
of steady-state inactivation curve to more negative potentials, associated with
a slower recovery from fast inactivation under eugenol indicates that this
molecule also binds to fast inactivated state. For currents undergoing slow in-
activation, a consistent reduction by eugenol indicates that the phenylpropene
additionally binds to the slow inactivated state. A frequency-dependent block-
ing effect of eugenol on NaV was observed, but the effect is smaller than that
induced by lidocaine. In conclusion, eugenol binds to several isoforms of
TTX-R NaV and to the different states of the proteins, leading to a channel
blockage.
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The scope of our study on wild-type and mutant-types of the voltage-dependent
sodium channel in rat skeletal muscle (Nav 1.4) was to examine the possible
binding site of primaquine (PQ) using a combined design and experimental ap-
proach. We applied a standard voltage-clamp in oocytes and in-silico methods,
mainly protein modeling and ligand docking. Previously, we demonstrate that
PQ blocks the voltage-dependent sodium current in rat myocytes, and these
block is concentration-dependent and voltage-independent fashion. Direct site
mutagenesis in the P-loop segment (W756C, W1239C and W1531A at the
